MicroRNA-370 Controls the Expression of MicroRNA-122 and Cpt1alpha and Affects Lipid Metabolism

Overview

Journal J Lipid Res

Publisher Elsevier

Specialty Biochemistry

Date 2010 Feb 4

PMID 20124555

Citations 139

Authors

Dimitrios Iliopoulos

Konstantinos Drosatos

Yaeko Hiyama

Ira J Goldberg

Vassilis I Zannis

Affiliations

Soon will be listed here.

Abstract

We previously observed that treatment of mice with a dominant negative form of cJun (dn-cJun) increased the expression of genes involved in lipid metabolism and modulated the expression of nine microRNAs (miR). To investigate the potential effect of these miRs on the expression of the genes of lipid metabolism, we performed studies in cultured HepG2 cells. Transfection of HepG2 cells with sense or antisense miR-370 or miR-122 upregulated and downregulated, respectively, the transcription factor sterol-regulatory element binding protein 1c (SREBP-1c) and the enzymes diacylglycerol acyltransferase-2 (DGAT2), fatty acid synthase (FAS), and acyl-CoA carboxylase 1 (ACC1) that regulate fatty acid and triglyceride biosynthesis. The other seven miRs identified by the miR array screening did not affect the expression of lipogenic genes. miR-370 upregulated the expression of miR-122. Furthermore, the effect of miR-370 on the expression of the lipogenic genes was abolished by antisense miR-122. miR-370 targets the 3' untranslated region (UTR) of Cpt1alpha, and it downregulated the expression of the carnitine palmitoyl transferase 1alpha (Cpt1alpha) gene as well as the rate of beta oxidation. Our data suggest that miR-370 acting via miR-122 may have a causative role in the accumulation of hepatic triglycerides by modulating initially the expression of SREBP-1c, DGAT2, and Cpt1alpha and, subsequently, the expression of other genes that affect lipid metabolism.

Citing Articles

Inhibition of triglyceride metabolism-associated enhancers alters lipid deposition during adipocyte differentiation.

Zeng S, Li Z, Li X, Du Q, Zhang Y, Zhong Z FASEB J. 2025; 39(2):e70347.

PMID: 39873971 PMC: 11774232. DOI: 10.1096/fj.202401137R.

β-Carotene Impacts the Liver MicroRNA Profile in a Sex-Specific Manner in Mouse Offspring of Western Diet-Fed Mothers: Results from Microarray Analysis by Direct Hybridization.

Abrego-Guandique D, Galmes S, Garcia-Rodriguez A, Cannataro R, Caroleo M, Ribot J Int J Mol Sci. 2024; 25(23).

PMID: 39684610 PMC: 11641259. DOI: 10.3390/ijms252312899.

miR-122/PPARβ axis is involved in hypoxic exercise and modulates fatty acid metabolism in skeletal muscle of obese rats.

Wang X, Feng L, Lu Y, Zhang H Heliyon. 2024; 10(4):e26572.

PMID: 38434053 PMC: 10906430. DOI: 10.1016/j.heliyon.2024.e26572.

miRNAs in Heart Development and Disease.

Lozano-Velasco E, Inacio J, Sousa I, Guimaraes A, Franco D, Moura G Int J Mol Sci. 2024; 25(3).

PMID: 38338950 PMC: 10855082. DOI: 10.3390/ijms25031673.

Advances in the regulation of adipogenesis and lipid metabolism by exosomal ncRNAs and their role in related metabolic diseases.

Liu C, Liu X, Li H, Kang Z Front Cell Dev Biol. 2023; 11:1173904.

PMID: 37791070 PMC: 10543472. DOI: 10.3389/fcell.2023.1173904.

References

Lim L, Lau N, Weinstein E, Abdelhakim A, Yekta S, Rhoades M . The microRNAs of Caenorhabditis elegans. Genes Dev. 2003; 17(8):991-1008. PMC: 196042. DOI: 10.1101/gad.1074403. View

Marchesini G, Marzocchi R, Agostini F, Bugianesi E . Nonalcoholic fatty liver disease and the metabolic syndrome. Curr Opin Lipidol. 2005; 16(4):421-7. DOI: 10.1097/01.mol.0000174153.53683.f2. View

Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M . Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell. 2006; 9(3):189-98. DOI: 10.1016/j.ccr.2006.01.025. View

Kajimoto K, Naraba H, Iwai N . MicroRNA and 3T3-L1 pre-adipocyte differentiation. RNA. 2006; 12(9):1626-32. PMC: 1557704. DOI: 10.1261/rna.7228806. View

He L, Hannon G . MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004; 5(7):522-31. DOI: 10.1038/nrg1379. View

You M, Matsumoto M, Pacold C, Cho W, Crabb D . The role of AMP-activated protein kinase in the action of ethanol in the liver. Gastroenterology. 2004; 127(6):1798-808. DOI: 10.1053/j.gastro.2004.09.049. View

Esau C, Davis S, Murray S, Yu X, Pandey S, Pear M . miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 2006; 3(2):87-98. DOI: 10.1016/j.cmet.2006.01.005. View

Bartel D . MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116(2):281-97. DOI: 10.1016/s0092-8674(04)00045-5. View

Puri P, Mirshahi F, Cheung O, Natarajan R, Maher J, Kellum J . Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease. Gastroenterology. 2007; 134(2):568-76. DOI: 10.1053/j.gastro.2007.10.039. View

10.

Drosatos K, Sanoudou D, Kypreos K, Kardassis D, Zannis V . A dominant negative form of the transcription factor c-Jun affects genes that have opposing effects on lipid homeostasis in mice. J Biol Chem. 2007; 282(27):19556-64. PMC: 2745720. DOI: 10.1074/jbc.M700986200. View

11.

Unger R . Lipotoxic diseases. Annu Rev Med. 2002; 53:319-36. DOI: 10.1146/annurev.med.53.082901.104057. View

12.

McGarry J, Brown N . The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem. 1997; 244(1):1-14. DOI: 10.1111/j.1432-1033.1997.00001.x. View

13.

Chitturi S, Abeygunasekera S, Farrell G, Holmes-Walker J, Hui J, Fung C . NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology. 2002; 35(2):373-9. DOI: 10.1053/jhep.2002.30692. View

14.

Grundy S, Cleeman J, Daniels S, Donato K, Eckel R, Franklin B . Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. Cardiol Rev. 2006; 13(6):322-7. View

15.

Ota T, Gayet C, Ginsberg H . Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents. J Clin Invest. 2007; 118(1):316-32. PMC: 2104481. DOI: 10.1172/JCI32752. View

16.

Sanyal A, Mirshahi F, Rizzo W, Contos M, Sterling R, Luketic V . Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology. 2001; 120(5):1183-92. DOI: 10.1053/gast.2001.23256. View

17.

Mersey B, Jin P, Danner D . Human microRNA (miR29b) expression controls the amount of branched chain alpha-ketoacid dehydrogenase complex in a cell. Hum Mol Genet. 2005; 14(22):3371-7. DOI: 10.1093/hmg/ddi368. View

18.

Jabri E . P-bodies take a RISC. Nat Struct Mol Biol. 2005; 12(7):564. DOI: 10.1038/nsmb0705-564. View

19.

Jin P, Zarnescu D, Ceman S, Nakamoto M, Mowrey J, Jongens T . Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway. Nat Neurosci. 2004; 7(2):113-7. DOI: 10.1038/nn1174. View

20.

Liu J, Valencia-Sanchez M, Hannon G, Parker R . MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nat Cell Biol. 2005; 7(7):719-23. PMC: 1855297. DOI: 10.1038/ncb1274. View